simply standard practice for toxic financing agreements?
they could convert everything and hold that 50% stake in the o/s
This is where management would need to have a poison pill in place to protect ownership. Say a huge amount & discount warrant or option award, to the CEO or board member.
Remember we're talking OTC correct. Things work differently at the big boards. Where poison pills are used for hostile takeovers. And at the OTC, poison pills are used to maintain startup ownership.
On the OTC, most funding debit conversion rights are 9.99% to help alleviate the need for a poison pill. That 9.99% is negotiated during funding. And something management requests from the VC. It can be any amount. I've seen 7.77% and 5.55% also.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.